tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541)
:1541
Hong Kong Market
1541
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
RESEARCH TOOLSreports

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (1541) Financial Statements

Compare
3 Followers

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H Financial Overview

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H's market cap is currently HK$5.16B. The company's EPS TTM is HK$-0.40756439429999997; its P/E ratio is -7.61; ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H is scheduled to report earnings on August 26, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 74.15M¥ 386.00K¥ 5.69M¥ 13.81M
Gross Profit¥ 74.15M¥ 7.70M¥ 5.69M¥ 13.81M
Operating Income¥ -308.04M¥ -364.67M¥ -364.45M¥ -210.47M
EBITDA¥ -295.63M¥ -355.35M¥ -384.49M¥ -718.88M
Net Income¥ -315.86M¥ -379.46M¥ -402.89M¥ -732.95M
Balance Sheet
Cash & Short-Term Investments¥ 752.12M¥ 608.56M¥ 635.21M¥ 668.33M
Total Assets¥ 922.00M¥ 874.59M¥ 839.98M¥ 892.84M
Total Debt¥ 136.36M¥ 74.77M¥ 14.62M¥ 18.54M
Net Debt¥ -341.24M¥ -232.21M¥ -620.59M¥ -649.79M
Total Liabilities¥ 243.69M¥ 126.30M¥ 60.76M¥ 2.49B
Stockholders' Equity¥ 678.90M¥ 748.29M¥ 779.22M¥ -1.60B
Cash Flow
Free Cash Flow¥ -138.44M¥ -370.25M¥ -261.93M¥ -315.79M
Operating Cash Flow¥ -128.03M¥ -367.55M¥ -238.71M¥ -190.54M
Investing Cash Flow¥ 37.95M¥ -294.85M¥ 49.00K¥ -108.72M
Financing Cash Flow¥ 258.93M¥ 331.04M¥ 179.38M¥ 793.03M
Currency in CNY

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H Earnings and Revenue History

Income Statement >

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H Debt to Assets

Balance Sheet >

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H Cash Flow

Cash Flow >

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H Forecast EPS vs Actual EPS

Earnings >